Arkolith/Insider Trading/MRNS/Form 4

Braunstein Scott

CHAIRMAN AND CEO, DirectorMARINUS PHARMACEUTICALS, INC. (MRNS) · full profile →Form 4 · filed Aug 7, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 5, 2024Sell(S)12K$1.13$14K299K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-020894) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML